From science to start up: developing a gene therapy for a rare blood disorder
Johan Flygare and the remarkable story of the genesis of Apriligen, a company which aims to find a cure for the rare blood disease, Diamond–Blackfan Anemia, DBA. Photo: Johan Persson. After 20 years of research on gene therapy and the rare blood disease, Diamond-Blackfan Anemia, DBA, researcher Johan Flygare had reached a point where he and his colleagues had done everything they could in the lab.
https://www.medicine.lu.se/article/science-start-developing-gene-therapy-rare-blood-disorder - 2025-08-27